How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?
Arihant Jain(California University of Pennsylvania), Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Ashish Bhalla(Office of Infectious Diseases), Alka Khadwal(Post Graduate Institute of Medical Education and Research), Deepesh Lad(Post Graduate Institute of Medical Education and Research), Nishant Jindal(Post Graduate Institute of Medical Education and Research), Ritin Mohindra(Post Graduate Institute of Medical Education and Research), Neelam Varma(Nagpur Institute of Technology), M. Joseph John(The University of Texas Health Science Center at Houston), Rishi Dhawan(All India Institute of Medical Sciences), Charanpreet Singh(Post Graduate Institute of Medical Education and Research), Savita Kumari(Post Graduate Institute of Medical Education and Research), Manoranjan Mahapatra(All India Institute of Medical Sciences), Vikas Suri(Post Graduate Institute of Medical Education and Research), Gaurav Prakash(Post Graduate Institute of Medical Education and Research)
Cited by 8
Related Papers
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
|Pediatric Blood & Cancer|2011|95
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis
|Pediatric Blood & Cancer|2013|85